Top Suppliers:I want be here


  • DC Chemicals Limited
  • China
  • Product Name: HMN-154
  • Price: $500.0/100mg $900.0/250mg $1700.0/1g
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

173528-92-2

173528-92-2 structure
173528-92-2 structure
  • Name: HMN-154
  • Chemical Name: 4-methoxy-N-[2-(2-pyridin-4-ylethenyl)phenyl]benzenesulfonamide
  • CAS Number: 173528-92-2
  • Molecular Formula: C20H18N2O3S
  • Molecular Weight: 366.43400
  • Catalog: Research Areas Cancer
  • Create Date: 2018-12-24 13:51:11
  • Modify Date: 2024-01-10 21:43:40
  • HMN-154 is a novel benzenesulfonamide anticancer compound; inhibits KB and colon38 cells with IC50 values of 0.0026 and 0.003 μg/mL, respectively.

Name 4-methoxy-N-[2-(2-pyridin-4-ylethenyl)phenyl]benzenesulfonamide
Synonyms HMN-154
Description HMN-154 is a novel benzenesulfonamide anticancer compound; inhibits KB and colon38 cells with IC50 values of 0.0026 and 0.003 μg/mL, respectively.
Related Catalog
Target

IC50: 0.0026 μg/mL (KB cells), 0.003 μg/mL (colon38 cells)[1]

In Vitro HMN-154 interacts with NF-YB and thereby interrupts the binding of the NF-Y heterotrimer to DNA. NF-YB and thymosin β-10 are specific cellular binding proteins of HMN-154 and that this shared region is necessary for the binding to HMN-154. HMN-154 inhibits DNA binding of NF-Y to the human major histocompatibility complex class II human leukocyte antigen DRA Y-box sequence in a dose-dependent manner. HMN-154 shows very strong cytotoxicity against KB and colon38 cells with an IC50 value of 0.0026 and 0.003 μg/mL, respectively. HMN-154/BSA binds recombinant NF-YB or thymosin β-10 and the binding is inhibited by the addition of HMN-154 as the competitor. The binding between HMN-154 and NF-YB is specific and depends on its cytotoxicity[1].
Cell Assay Cells are seeded into a 96-well microplate at a cell density of 10000/well. Drug is added on the next day, and the plate then is incubated for 72 h at 37°C. The growth inhibitory concentration is measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay[1].
References

[1]. Tanaka H, et al. Isolation of cDNAs encoding cellular drug-binding proteins using a novel expression cloning procedure: drug-western. Mol Pharmacol. 1999 Feb;55(2):356-63.

Density 1.313g/cm3
Boiling Point 553.7ºC at 760 mmHg
Molecular Formula C20H18N2O3S
Molecular Weight 366.43400
Flash Point 288.6ºC
Exact Mass 366.10400
PSA 76.67000
LogP 5.21520
Vapour Pressure 2.67E-12mmHg at 25°C
Index of Refraction 1.651
Storage condition 2-8℃

~%

173528-92-2 structure

173528-92-2

Literature: Nippon Shinyaku Company, Limited Patent: US5972976 A1, 1999 ;